BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 206 filers reported holding BEAM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $257,579 | +4.3% | 8,067 | 0.0% | 0.17% | -3.4% |
| Q1 2023 | $247,012 | -21.7% | 8,067 | 0.0% | 0.18% | -84.0% |
| Q4 2022 | $315,500 | -49.4% | 8,067 | -38.3% | 1.10% | -46.2% |
| Q3 2022 | $623,000 | +23.1% | 13,067 | 0.0% | 2.05% | +65.2% |
| Q2 2022 | $506,000 | -32.4% | 13,067 | 0.0% | 1.24% | -4.0% |
| Q1 2022 | $749,000 | -27.1% | 13,067 | +1.3% | 1.29% | +10.9% |
| Q4 2021 | $1,028,000 | -8.4% | 12,900 | 0.0% | 1.16% | -0.5% |
| Q3 2021 | $1,122,000 | -32.4% | 12,900 | 0.0% | 1.17% | -38.1% |
| Q2 2021 | $1,660,000 | +87.4% | 12,900 | +16.6% | 1.89% | +60.7% |
| Q1 2021 | $886,000 | -0.2% | 11,067 | +1.8% | 1.18% | -3.5% |
| Q4 2020 | $888,000 | +231.3% | 10,875 | 0.0% | 1.22% | +140.4% |
| Q3 2020 | $268,000 | -12.1% | 10,875 | 0.0% | 0.51% | -59.4% |
| Q2 2020 | $305,000 | +10.9% | 10,875 | -28.9% | 1.25% | +1190.7% |
| Q1 2020 | $275,000 | – | 15,300 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |